Share this article
BNB Tops $760 Amid Corporate Adoption and New Binance Features
BNB's price rose nearly 2% to top $760, driven by a surge in volume and coordinated buying that pushed through technical resistance levels.
Aug 4, 2025, 4:48 p.m.
What to know:
- BNB's price rose nearly 2% to top $760, driven by a surge in volume and coordinated buying that pushed through technical resistance levels.
- The price action coincides with recent developments from Binance, including the launch of a web of its Binance Wallet and the opening of bitcoin options writing to all users, which may have contributed to growing confidence in BNB.
- Several U.S.-listed companies, including CEA Industries, Liminatus Pharma, Windtree Therapeutics and Nano Labs, have announced significant financial commitments to BNB.
The price of BNB climbed nearly 2% in the past 24 hours to top the $760 mark, with data showing a burst of activity behind the price rise.
Volume spiked nearly 50% above daily averages, according to CoinDesk Research's technical analysis model. The price action followed a textbook two-phase accumulation: early consolidation, then a breakout driven by coordinated buying that pushed through technical resistance levels.
STORY CONTINUES BELOW
Don't miss another story.Subscribe to the Crypto Daybook Americas Newsletter today. See all newsletters
This tailwind coincides with recent developments from Binance, a key player in BNB’s ecosystem. The crypto exchange launched a web version of its Binance Wallet, letting users approve trades for up to seven days in advance to reduce friction for high-frequency or active traders.
Binance also opened bitcoin options writing to all users, removing VIP restrictions. Traders still need to pass risk checks and post collateral. They gain 20% discounts on the platform’s fees, including on BNB-denominated contracts.
A wave of corporate adoption is signaling growing confidence in BNB, with several U.S.-listed companies announcing significant financial commitments to the cryptocurrency. CEA Industries (VAPE), which, with backing from Binance co-founder Changpeng Zhao’s family office, Yzi Labs, unveiled an ambitious plan to raise up to $1.2 billion.
Clinical-stage firm Liminatus Pharma (LIMN) is also launching a dedicated BNB investment arm with a $500 million funding target, while Windtree Therapeutics (WINT) has disclosed a strategy to acquire $700 million in BNB.
Meanwhile, tech company Nano Labs has already taken action, reporting the purchase of 128,000 BNB as a cornerstone of its new crypto treasury initiative.
Technical Analysis Overview
BNB’s price action shows hallmarks of a managed rally. Volume concentrations far exceeded hourly norms at key points in the move, signaling coordinated buying.
A breakout through resistance levels at $759 and $761 came with minimal slippage, often an indicator of deeper liquidity and pre-structured entry points typical of corporate treasuries.
The asset held firm around $745.81 during earlier consolidation, establishing a clear support zone. From there, it climbed in measured steps, breaking technical ceilings and holding gains.
Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.
More For You
KuCoin captured a record share of centralised exchange volume in 2025, with more than $1.25tn traded as its volumes grew faster than the wider crypto market.
What to know:
- KuCoin recorded over $1.25 trillion in total trading volume in 2025, equivalent to an average of roughly $114 billion per month, marking its strongest year on record.
- This performance translated into an all-time high share of centralised exchange volume, as KuCoin’s activity expanded faster than aggregate CEX volumes, which slowed during periods of lower market volatility.
- Spot and derivatives volumes were evenly split, each exceeding $500 billion for the year, signalling broad-based usage rather than reliance on a single product line.
- Altcoins accounted for the majority of trading activity, reinforcing KuCoin’s role as a primary liquidity venue beyond BTC and ETH at a time when majors saw more muted turnover.
- Even as overall crypto volumes softened mid-year, KuCoin maintained elevated baseline activity, indicating structurally higher user engagement rather than short-lived volume spikes.
More For You
Strategy shares register first six-month losing streak since adoption of bitcoin strategy in 2020
Crypto analyst Chris Millas has highlighted an unusually persistent slump in Strategy shares, breaking with past drawdown patterns even as the firm continued accumulating bitcoin.
What to know:
- Strategy shares fell in each of the final six months of 2025, marking the first time since the firm adopted bitcoin in August 2020 as a treasury reserve asset.
- The decline stands out for its persistence, as past selloffs were often followed by sharp rebounds.
- The stock sharply underperformed both bitcoin and the Nasdaq 100 despite the firm's continued BTC purchases.
Top Stories
